Nuvama, a brokerage firm, has identified seven top-performing stocks in the pharma sector. These companies have shown strong revenue and earnings growth in the second quarter of the financial year 2026. Nuvama’s top picks include Ajanta Pharma, IPCA Laboratories, Torrent Pharmaceuticals, Divi’s Laboratories, Neuland Laboratories, Aurobindo Pharma, and Biocon.